ArticlePLoS neglected tropical diseases2018
Forecasting the effectiveness of indoor residual spraying for reducing dengue burden.
Article in PLoS neglected tropical diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
35 citing papers in PubMed.
- Randomized Trial of Targeted Indoor Spraying to Prevent Aedes-Borne Diseases.The New England journal of medicine · 2025Trial
- Community deployment of metofluthrin emanators to control indoor Aedes aegypti: Efficacy results from a crossover trial in Yucatan, Mexico.PLoS neglected tropical diseases · 2025Trial
- The entomological impact of passive metofluthrin emanators against indoor Aedes aegypti: A randomized field trial.PLoS neglected tropical diseases · 2021Trial
- Identifying Key Factors in Predicting Chikungunya and Zika Transmission Across French Polynesia and the French West Indies: A Data-Driven Probabilistic and Mathematical Modeling Approach.Bulletin of mathematical biology · 2026Article
- Direct and Indirect Entomological Efficacy of Targeted Indoor Residual Spraying againstbioRxiv : the preprint server for biology · 2026Article
- Spatial and temporal analysis on the impact of ultra-low volume indoor insecticide spraying on Aedes aegypti household density.Parasites & vectors · 2024Article
- Agent-based modeling of the COVID-19 pandemic in Florida.Epidemics · 2024Article
- Behavioral responses and life history traits of Taiwanese and Indonesian populations of Aedes aegypti surviving deltamethrin-clothianidin treatment.Parasites & vectors · 2024Article
- Article
- Targeted indoor residual insecticide applications shift Aedes aegypti age structure and arbovirus transmission potential.Scientific reports · 2023Article
- MappingPNAS nexus · 2023Article
- Article
- Article
- Review
- Residual efficacy of the neonicotinoid insecticide clothianidin against pyrethroid-resistant Aedes aegypti.Pest management science · 2023Article
- Short-term and long-term epidemiological impacts of sustained vector control in various dengue endemic settings: A modelling study.PLoS computational biology · 2022Article
- Article
- Efficacy of targeted indoor residual spraying with the pyrrole insecticide chlorfenapyr against pyrethroid-resistant Aedes aegypti.PLoS neglected tropical diseases · 2021Article
- Prevalence of arbovirus antibodies in young healthy adult population in Brazil.Parasites & vectors · 2021Article
- Identifying urban hotspots of dengue, chikungunya, and Zika transmission in Mexico to support risk stratification efforts: a spatial analysis.The Lancet. Planetary health · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundHistorically, mosquito control programs successfully helped contain malaria and yellow fever, but recent efforts have been unable to halt the spread of dengue, chikungunya, or Zika, all transmitted by Aedes mosquitoes. Using a dengue transmission model and results from indoor residual spraying (IRS) field experiments, we investigated how IRS-like campaign scenarios could effectively control dengue in an endemic setting. METHODS AND
findingsIn our model, we found that high levels of household coverage (75% treated once per year), applied proactively before the typical dengue season could reduce symptomatic infections by 89.7% (median of 1000 simulations; interquartile range [IQR]:[83.0%, 94.8%]) in year one and 78.2% (IQR: [71.2%, 88.0%]) cumulatively over the first five years of an annual program. Lower coverage had correspondingly lower effectiveness, as did reactive campaigns. Though less effective than preventative campaigns, reactive and even post-epidemic interventions retain some effectiveness; these campaigns disrupt inter-seasonal transmission, highlighting an off-season control opportunity. Regardless, none of the campaign scenarios maintain their initial effectiveness beyond two seasons, instead stabilizing at much lower levels of benefit: in year 20, median effectiveness was only 27.3% (IQR: [-21.3%, 56.6%]). Furthermore, simply ceasing an initially successful program exposes a population with lowered herd immunity to the same historical threat, and we observed outbreaks more than four-fold larger than pre-intervention outbreaks. These results do not take into account evolving insecticide resistance, thus long-term effectiveness may be lower if new, efficacious insecticides are not developed.
conclusionsUsing a detailed agent-based dengue transmission model for Yucatán State, Mexico, we predict that high coverage indoor residual spraying (IRS) interventions can largely eliminate transmission for a few years, when applied a few months before the typical seasonal epidemic peak. However, vector control succeeds by preventing infections, which precludes natural immunization. Thus, as a population benefits from mosquito control, it gradually loses naturally acquired herd immunity, and the control effectiveness declines; this occurs across all of our modeled scenarios, and is consistent with other empirical work. Long term control that maintains early effectiveness would require some combination of increasing investment, complementary interventions such as vaccination, and control programs across a broad region to diminish risk of importation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.